Michael J Tortorici

US Patent:

20190183991, Jun 20, 2019

Filed:

Aug 23, 2017

Appl. No.:

16/327553

Inventors:

- Marburg, DE
Dipti PAWASKAR - Philadelphia PA, US
Michael TORTORICI - Berwyn PA, US
Ingo PRAGST - Edertal, DE
Ying ZHANG - Chesterbrook PA, US

International Classification:

A61K 38/57
A61P 7/10
A61K 9/00
G01N 33/68
G16H 20/10

Abstract:

The invention relates to a method for determining a dosing scheme for the treatment of hereditary angioedema and/or the prevention of hereditary angioedema attacks with C1 esterase inhibitor to optimize treatment response in an individual patient. Accordingly, the present invention provides means for determining individual C1 esterase inhibitor dosing schemes that result in an optimal treatment/prevention outcome.